System and method for treating an adverse cardiac condition using combined pacing and drug delivery
First Claim
1. A method of treating cardiac arrhythmia, comprising:
- producing, by use of a patient actuatable non-implanted activator, an activation signal in response to a patient sensing a perceived cardiac arrhythmic condition;
confirming, by an implantable medical device provided within the patient, that the patient is experiencing an actual cardiac arrhythmic condition;
generating, by the non-implanted activator in communication with the implantable medical device, a perceivable initiating signal instructing the patient or a physician to commence with a drug delivery regimen to treat the actual cardiac arrhythmic condition; and
initiating a pacing regimen to treat the actual cardiac arrhythmic condition.
1 Assignment
0 Petitions
Accused Products
Abstract
A system and method of treating an adverse cardiac condition, such as cardiac arrhythmia or a non-arrhythmic event, involves producing, by use of a patient actuatable non-implanted activator, an activation signal in response to a patient sensing a perceived adverse cardiac condition. The method further involves confirming, by an implantable medical device provided within the patient, that the patient is experiencing an actual adverse cardiac condition. A perceivable initiating signal instructing the patient or a physician to commence with a drug delivery regimen to treat the actual cardiac adverse condition is generated by the non-implanted activator. In one approach, the implantable medical device operates in a safe mode of pacing during drug treatment of the actual adverse cardiac condition. In another approach, an appropriate pacing, cardioversion or defibrillation regimen is initiated to treat the actual adverse cardiac condition.
52 Citations
63 Claims
-
1. A method of treating cardiac arrhythmia, comprising:
-
producing, by use of a patient actuatable non-implanted activator, an activation signal in response to a patient sensing a perceived cardiac arrhythmic condition;
confirming, by an implantable medical device provided within the patient, that the patient is experiencing an actual cardiac arrhythmic condition;
generating, by the non-implanted activator in communication with the implantable medical device, a perceivable initiating signal instructing the patient or a physician to commence with a drug delivery regimen to treat the actual cardiac arrhythmic condition; and
initiating a pacing regimen to treat the actual cardiac arrhythmic condition. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
-
-
12. A method of treating atrial arrhythmia, comprising:
-
producing, by use of a patient actuatable non-implanted activator, an activation signal in response to a patient sensing a perceived atrial arrhythmic condition;
confirming that the patient is experiencing an actual atrial arrhythmic condition;
generating, by the non-implanted activator, a perceivable initiating signal instructing the patient or a physician to commence with a drug delivery regimen to treat the actual atrial arrhythmic condition; and
initiating a pacing regimen to treat the actual atrial arrhythmic condition, the pacing regimen accounting for presence of a drug delivered to the patient as part of the drug delivery regimen. - View Dependent Claims (13, 14, 15, 16, 17, 18, 19, 20, 21)
-
-
22. A method of treating cardiac arrhythmia, comprising:
-
producing, by use of a patient actuatable non-implanted activator, an activation signal in response to sensing a perceived cardiac arrhythmic condition by a patient or an implantable medical device provided within the patient;
confirming, by the implantable medical device, that the patient is experiencing an actual cardiac arrhythmic condition; and
generating, by the non-implanted activator in communication with the implanted medical device, a perceivable initiating signal instructing the patient or a physician to commence with a drug delivery regimen to treat the actual cardiac arrhythmic condition. - View Dependent Claims (23, 24, 25)
-
-
26. A system for treating cardiac arrhythmia, comprising:
-
a non-implanted activator actuatable by a patient, the activator comprising a communication unit and producing an activation signal in response to a patient sensing a perceived cardiac arrhythmic condition; and
an implantable medical device, comprising;
communication circuitry for communicating with the non-implanted activator;
an energy detection and delivery system, comprising a lead system, for detecting cardiac signals and delivering energy to the heart in accordance with a pacing regimen; and
a control system, the control system, in response to the activation signal, confirming that the patient is experiencing an actual cardiac arrhythmic condition and generating a confirmation signal, the control system initiating the pacing regimen to treat the actual cardiac arrhythmic condition, and the non-implantable activator generating a perceivable initiating signal instructing the patient or a physician to commence with a drug delivery regimen to treat the actual cardiac arrhythmic condition. - View Dependent Claims (27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)
-
-
40. A method of treating an adverse cardiac condition, comprising:
-
producing, by use of a patient actuatable non-implanted activator, an activation signal in response to a patient sensing a perceived adverse cardiac condition;
confirming, by an implantable medical device provided within the patient, that the patient is experiencing an actual adverse cardiac condition;
generating, by the non-implanted activator in communication with the implantable medical device, a perceivable initiating signal instructing commencement of a drug delivery regimen to treat the actual adverse cardiac condition; and
initiating a safe mode of pacing appropriate for the adverse cardiac condition. - View Dependent Claims (41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56)
-
-
57. A system for treating an adverse non-arrhythmic cardiac condition, comprising:
-
a non-implanted activator actuatable by a patient, the activator comprising a communication unit and producing an activation signal in response to a patient sensing a perceived adverse non-arrhythmic cardiac condition; and
an implantable medical device, comprising;
communication circuitry for communicating with the non-implanted activator;
an energy detection and delivery system, comprising a lead system, for detecting cardiac signals and delivering energy to the heart in accordance with a pacing regimen; and
a control system, the control system, in response to the activation signal, confirming that the patient is experiencing an actual adverse non-arrhythmic cardiac condition and generating a confirmation signal, the control system initiating the pacing regimen to treat the actual adverse non-arrhythmic cardiac condition, and the non-implantable activator generating a perceivable initiating signal instructing the patient or a physician to commence with a drug delivery regimen to treat the actual adverse non-arrhythmic cardiac condition. - View Dependent Claims (58, 59, 60, 61, 62, 63)
-
Specification